Best Equity Analyst Interviews of 2019

December 13, 2019

Buy ($175)

Companies covered: Spark Therapeutics, Inc. (NASDAQ:ONCE), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY), Audentes Therapeutics (NASDAQ:BOLD), Novartis AG (NYSE:NVS), bluebird bio, Inc. (NASDAQ:BLUE), Novocure Ltd. (NASDAQ:NVCR), Fastenal Company (NASDAQ:FAST), W.W. Grainger, Inc. (NYSE:GWW), MSC Industrial Direct Company, Inc. (NYSE:MSM), Rockwell Automation, Inc. (NYSE:ROK), Emerson Electric Company (NYSE:EMR), Lennox International, Inc. (NYSE:LII), Ingersoll-Rand plc (Ireland) (NYSE:IR), Kaman Corporation (NYSE:KAMN), United Technologies Corporation (NYSE:UTX), Johnson Controls, Inc. (NYSE:JCI), Fortive Corp (NYSE:FTV), Nordson Corporation (NASDAQ:NDSN), Apple Inc. (NASDAQ:AAPL), Cisco Systems, Inc. (NASDAQ:CSCO), Juniper Networks, Inc. (NYSE:JNPR), Lincoln Electric Holdings, Inc. (NASDAQ:LECO), Amazon.com, Inc. (NASDAQ:AMZN), Colfax Corporation (NYSE:CFX), IDEX Corporation (NYSE:IEX), HCP, Inc. (NYSE:HCP), Physicians Realty Trust (NYSE:DOC), Global Medical REIT Inc (NYSE:GMRE), Community Healthcare Trust (NYSE:CHCT), Senior Housing Properties Trust (NYSE:SNH), Medical Properties Trust, Inc. (NYSE:MPW), New Senior Investment Group Inc. (NYSE:SNR), American Campus Communities Inc (NYSE:ACC), Invitation Homes (NYSE:INVH), American Homes 4 Rent (NYSE:AMH), Welltower Inc (NYSE:WELL), Ventas, Inc. (NYSE:VTR), Five Star Senior Living (NASDAQ:FVE), Stryker Corporation (NYSE:SYK), Zimmer Biomet Holdings Inc. (NYSE:ZBH), Vericel Corporation (NASDAQ:VCEL), OrthoPediatrics Corp. (NASDAQ:KIDS), ConforMIS Inc (NASDAQ:CFMS), Spine Injury Solutions (OTCMKTS:SPIN), Glaukos Corp (NYSE:GKOS), Intuitive Surgical, Inc. (NASDAQ:ISRG), Globus Medical, Inc. (NYSE:GMED), AxoGen, Inc. (NASDAQ:AXGN), MediWound Ltd. (NASDAQ:MDWD), Smith & Nephew SNATS, Inc. (NYSE:SNN), Medtronic, Inc. (NYSE:MDT), Abbott Laboratories (NYSE:ABT), Allergan, Inc. (NYSE:AGN), Ocular Therapeutix, Inc. (NASDAQ:OCUL), Progressive Corporation (The) (NYSE:PGR), The Travelers Companies, Inc. (NYSE:TRV), Hartford Financial Services Group, Inc. (The) (NYSE:HIG), The Hanover Insurance Group, Inc. (NYSE:THG), RenaissanceRe Holdings Ltd. (NYSE:RNR), The Navigators Group, Inc. (NASDAQ:NAVG), Selective Insurance Group, Inc. (NASDAQ:SIGI), Axis Capital Holdings Limited (NYSE:AXS), ProLogis, Inc. (NYSE:PLD), Simon Property Group, Inc. (NYSE:SPG), Taubman Centers, Inc. (NYSE:TCO), Boston Properties, Inc. (NYSE:BXP), CBRE Group, Inc. (NYSE:CBRE), Front Yard Residential Corp. (NYSE:RESI), Cushman & Wakefield PLC (NYSE:CWK), Fidelity National Information Services, Inc. (NYSE:FIS), Fiserv, Inc. (NASDAQ:FISV), Jack Henry & Associates, Inc. (NASDAQ:JKHY), Bottomline Technologies, Inc. (NASDAQ:EPAY), Q2 Holdings, Inc. (NYSE:QTWO), First Data Corp (NYSE:FDC), Global Payments Inc. (NYSE:GPN), Total System Services, Inc. (NYSE:TSS), Mastercard Incorporated (NYSE:MA), Visa Inc. (NYSE:V), ACI Worldwide, Inc. (NASDAQ:ACIW), Square Inc (NYSE:SQ), Paypal Holdings Inc (NASDAQ:PYPL), Equifax, Inc. (NYSE:EFX), Experian plc (ADR) (OTCMKTS:EXPGY), Fair Isaac Corporation (NYSE:FICO), CoStar Group, Inc. (NASDAQ:CSGP), Worldpay (NYSE:WP), LiveRamp Holdings (NYSE:RAMP), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Sangamo Therapeutics, Inc. (NASDAQ:SGMO), uniQure N.V. (NASDAQ:QURE), Regenxbio Inc (NASDAQ:RGNX), BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Pfizer, Inc. (NYSE:PFE), PTC Therapeutics, Inc. (NASDAQ:PTCT), Amicus Therapeutics, Inc. (NASDAQ:FOLD), Axovant Sciences Ltd. (NASDAQ:AXGT), Ophthotech Corporation (NASDAQ:OPHT), Gilead Sciences, Inc. (NASDAQ:GILD), Celgene Corporation (NASDAQ:CELG), MeiraGTx Holdings PLC (NASDAQ:MGTX)